Familial cerebral amyloid angiopathy due to the iowa mutation in an irish family.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24878480)

Published in Can J Neurol Sci on July 01, 2014

Authors

Tzehow Mok, Albi J Chalissery, Susan Byrne, Lisa Costelloe, Leo Galvin, Harry V Vinters, Michael A Farrell, Francesca M Brett, Joan T Moroney

Articles by these authors

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med (2008) 17.09

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94

The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia (2010) 6.23

PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA (2012) 5.40

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Optimization of scarless human stem cell genome editing. Nucleic Acids Res (2013) 2.78

Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discov (2011) 2.77

Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71

Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62

CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52

The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry (2011) 2.45

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol (2009) 2.30

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal (2009) 2.23

Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells (2009) 2.10

Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke (2002) 2.08

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (2005) 2.07

Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci U S A (2007) 2.06

Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol (2005) 2.05

Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia (2009) 1.99

Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med (2012) 1.92

Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol (2004) 1.90

Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci (2009) 1.88

Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology (2002) 1.79

Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci (2011) 1.79

Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (2010) 1.78

Middle cerebral artery occlusion in the rabbit using selective angiography: application for assessment of thrombolysis. Stroke (2008) 1.76

Breast lesions: evaluation with US strain imaging--clinical experience of multiple observers. Radiology (2006) 1.76

Spontaneous adrenal hemorrhage during pregnancy: a review of the literature and a case report of successful conservative management. Obstet Gynecol Surv (2005) 1.75

Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain (2007) 1.73

Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry (2012) 1.70

Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol (2009) 1.69

Parkin disease: a clinicopathologic entity? JAMA Neurol (2013) 1.68

Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol (2003) 1.66

Inflammatory pseudotumor of the spleen associated with a clonal Epstein-Barr virus genome. Case report and review of the literature. Am J Clin Pathol (2003) 1.66

Vascular cognitive impairment. Nat Clin Pract Neurol (2006) 1.64

Accelerated epigenetic aging in Down syndrome. Aging Cell (2015) 1.61

Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease. Neurology (2009) 1.59

Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci U S A (2011) 1.58

Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet (2003) 1.58

Hydrophilic polymer emboli: an under-recognized iatrogenic cause of ischemia and infarct. Mod Pathol (2010) 1.55

Different features of histopathological subtypes of pediatric focal cortical dysplasia. Ann Neurol (2008) 1.55

Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol (2010) 1.55

Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet (2012) 1.52

Chronic perineal pain caused by pudendal nerve entrapment: anatomy and CT-guided perineural injection technique. AJR Am J Roentgenol (2003) 1.51

Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis. Radiology (2006) 1.46

Testing a new cognitive behavioural treatment for obesity: A randomized controlled trial with three-year follow-up. Behav Res Ther (2010) 1.43

Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol (2004) 1.43

Adult-onset nemaline myopathy presenting as respiratory failure. Respir Care (2008) 1.40

Dementia with parkinsonism: what is the diagnosis? Rev Neurol Dis (2004) 1.38

Intravascular polymer material after coil embolization of a giant cerebral aneurysm. Hum Pathol (2009) 1.38

Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 1.35

Electroanatomic remodeling of the left stellate ganglion after myocardial infarction. J Am Coll Cardiol (2012) 1.35

Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res (2002) 1.33

Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav (2006) 1.32

Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol (2010) 1.32

FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report. Epilepsia (2006) 1.31

"True" sporadic ALS associated with a novel SOD-1 mutation. Ann Neurol (2002) 1.31

Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol (2005) 1.30

Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases. Brain Pathol (2007) 1.30

Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther (2012) 1.30

The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol (2002) 1.29

Cerebral hemispherectomy in pediatric patients with epilepsy: comparison of three techniques by pathological substrate in 115 patients. J Neurosurg (2004) 1.29

Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Am J Pathol (2008) 1.27

Protocol for the examination of specimens from patients with tumors of the brain/spinal cord. Arch Pathol Lab Med (2008) 1.25

Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res (2003) 1.24

Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol (2015) 1.24

Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephaly. Brain (2005) 1.24

A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron (2006) 1.23

Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis (2009) 1.22

Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord (2009) 1.20

Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet (2013) 1.20

The eating disorder examination: norms and construct validity with young and middle adolescent girls. Int J Eat Disord (2008) 1.19

Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. Brain (2013) 1.19

Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology (2003) 1.18

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav Immun (2011) 1.18

Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum Mutat (2010) 1.17

Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. J Endourol (2010) 1.15

Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010. PLoS One (2013) 1.15

Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology (2013) 1.13

Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J Neurosci Res (2010) 1.13

Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med (2004) 1.12

Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anesthesia. Anesth Analg (2004) 1.12

Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol (2009) 1.12

Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology (2013) 1.11

Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases. J Neurooncol (2010) 1.11

Late-onset neuroaxonal leucoencephalopathy with spheroids and vascular amyloid. Eur Neurol (2003) 1.10

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS (2012) 1.09

Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum Mol Genet (2010) 1.08

Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. J Biol Chem (2013) 1.07

De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients. Cancer Discov (2013) 1.07

Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector. J Pharmacol Exp Ther (2002) 1.07

Pleural nodularity in a patient with pyrexia of unknown origin. Chest (2002) 1.07